实用肝脏病杂志 ›› 2021, Vol. 24 ›› Issue (6): 863-866.doi: 10.3969/j.issn.1672-5069.2021.06.024

• 肝硬化 • 上一篇    下一篇

失代偿期肝硬化患者并发医院内感染病原菌类别及其耐药特点分析*

柳梅, 时永红, 郇娟, 陈茂丽   

  1. 271100 济南市 山东第一医科大学附属济南市人民医院感染病科
  • 收稿日期:2020-12-25 发布日期:2021-11-15
  • 作者简介:柳梅,女,40岁,医学硕士,主治医师。E-mail:laiwulm@126.com
  • 基金资助:
    *山东省医药卫生科技发展计划基金资助项目(编号:2017WS753)

Prevalence of nosocomial infection and resistance of pathogens in patients with decompensated liver cirrhosis

Liu Mei, Shi Yonghong, Ying Juan, et al   

  1. Department of Infectious Diseases, People's Hospital Affiliated to Shandong First Medical University, Jinan 271100, Shandong Province, China
  • Received:2020-12-25 Published:2021-11-15

摘要: 目的 探讨失代偿期肝硬化患者并发医院内感染病原菌类别及耐药特点,为失代偿期肝硬化患者医院内感染的防治提供参考依据。方法 2018年1月~2020年1月我科诊治的失代偿期肝硬化患者67例,分析67例患者并发医院内感染发生情况,采用VITEK-2Compact全自动微生物分析系统鉴定感染病原菌种类,采用K-B纸片琼脂扩散法对病原菌进行药敏试验。结果 在本组67例失代偿期肝硬化患者中,发生医院内感染者24例(35.8%),其中腹腔感染占比为45.8%、肺部感染占比为33.3%和泌尿道感染占比为20.8%;感染组年龄≥60岁、消化道出血、住院时间长和Child C级占比显著高于未感染组(P<0.05),而血清白蛋白水平和预防性应用抗生素占比显著低于未感染组(P<0.05);Logistic回归分析发现年龄(OR=1.16,95%CI:1.09~1.24)、住院时间(OR=1.13,95%CI:1.05~1.93)、消化道出血(OR=1.50,95%CI:1.09~2.09)、血清白蛋白(OR=1.11,95%CI:1.02~1.20)、是否预防性应用抗生素(OR=1.48,95%CI:1.21~1.81)为失代偿期肝硬化患者并发医院内感染的影响因素(P<0.05);在24例感染患者标本中培养出37株病原菌,其中革兰阴性菌21株(56.8%),革兰阳性菌11株(29.7%),真菌5株(13.5%);大肠埃希菌对氨苄西林和哌拉西林耐药率高,肺炎克雷伯菌对抗菌药物的耐药率均低于16.7%,金黄色葡萄球菌对庆大霉素的耐药率为60.0%。结论 失代偿期肝硬化患者并发医院内感染风险高,其影响因素多且复杂,病原菌分布以革兰阴性菌为主,但病原菌耐药现象明显,临床上需加强对高危感染人群的重视,必要时预防性应用敏感性抗菌药物,对减少并发医院内感染的发生尤为重要。

关键词: 肝硬化, 失代偿期, 医院内感染, 病原菌, 耐药

Abstract: Objective The paper aimed to investigate the prevalence of nosocomial infection and resistance of pathogens in patients with decompensated liver cirrhosis (LC). Methods A total of 67 patients with decompensated liver cirrhosis were enrolled in the Department of Infectious Diseases in our hospital between January 2018 and January 2020, and the prevalence of nosocomial infections were retrieved. The pathogens in patients with nosocomial infection was identified by VITEK-2 Compact full-automatic microbial analysis system. The drug sensitivity tests of pathogens were conducted by KB paper agar diffusion method. Results Of the 67 patients with decompensated cirrhosis, 24 cases (35.8%) were identified as with nosocomial infection, and out of which, the main infection sites were abdominal (45.8%), lung (33.3%) and urinary infection (20.8%); the percentages of younger than 60 years old, with gastrointestinal bleeding, long hospitalization and Child class C in infected patients were significantly higher than in those without infection (P<0.05), while serum albumin level and percentage of preventive administration of antibiotics in infected group were significantly lower than those in non-infected group (P<0.05); it was found by Logistic regression analysis that the age (OR=1.16, 95%CI:1.09-1.24), hospitalization time (OR=1.13, 95%CI: 1.05-1.93), gastrointestinal bleeding (OR=1.50, 95%CI: 1.09-2.09), serum albumin (OR=1.11, 95%CI: 1.02-1.20) and preventive antibiotics (OR=1.48, 95%CI: 1.21-1.81) were the impacting factors of nosocomial infection in patients with decompensated cirrhosis (P<0.05); out of the 24 patients with nosocomial infections, there were 37 strains of pathogens, including 21 strains of Gram-negative bacteria (56.8%), 11 strains of Gram-positive bacteria (29.7%) and 5 strains of fungi (13.5%) separated; the resistance rate of Escherichia Coli was high to ampicillin and piperacillin, the resistance rate of Klebsiella Pneumoniae to antimicrobial agents was lower than 16.7%, and that of Staphylococcus Aureus to gentamicin was higher than 60.0%. Conclusion The risk of nosocomial infection is high in patients with hospitalized decompensated liver cirrhosis, and its influencing factors are many and complex. The common pathogens are mainly Gram-negative bacteria, but the drug resistance of pathogens is also common. In clinical practice, it is necessary to pay more attention to high-risk infection population. When necessary, the preventive administration of sensitive antibacterial agents is of particularly importance to reduce the occurrence of secondary nosocomial infection in patients with decompensated cirrhosis.

Key words: Liver cirrhosis, Nosocomial infection, Pathogens, Drug resistance